<DOC>
	<DOCNO>NCT01607528</DOCNO>
	<brief_summary>Liver cirrhosis 10th common cause death western world . Infection common precipitant deterioration liver function cirrhosis . Endotoxin , derive gram-negative organism gut , enter circulation due increase gut permeability contribute neutrophil dysfunction , infection risk mortality alcoholic cirrhotics . As probiotic decrease gram-negative organism gut and/or decrease gut permeability , investigator hypothesize probiotic treatment would restore neutrophil function prevent infection alcoholic cirrhosis . The investigator hypothesize administration probiotic mixture patient liver cirrhosis improve innate immune function alteration gut bacterial flora gut barrier integrity . The aim randomise , double-blinded placebo-controlled study ass whether food supplementation probiotic mixture improve neutrophil phagocytic capacity patient cirrhosis decrease incidence significant infection . 92 patient alcoholic cirrhosis include accord sample size calculation preliminary data . Patients randomize two group : Group 1 receive probiotic mixture Group 2 receive similar look taste placebo without bacteria . The recruited patient treat 6 month . Besides routine clinical laboratory assessment , neutrophil function , toll-like receptor expression , endotoxin level , bacterial DNA , cytokine level , albumin oxidation , gut permeability analysis gut microflora perform . Furthermore nutritional status quality life assess . Primary endpoint neutrophil phagocytosis . Secondary endpoint significant infection , neutrophil oxidative burst , neutrophil toll-like receptor expression , endotoxin level , bacterial DNA ; cytokine level , albumin oxidation , gut barrier function bacterial flora , nutritional status quality life . If hypothesis hold true , probiotic provide easily applicable cost effective method improve immune function prevent infection liver cirrhosis . It possible improve survival patient liver cirrhosis .</brief_summary>
	<brief_title>Influence Probiotics Infections Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>â€¢ Patients age 1880 year Clinical radiological evidence cirrhosis , and/or biopsy proven liver cirrhosis cause Informed consent ChildPugh score &gt; 11 Abstinence alcohol &lt; 2 week time screen inclusion Clinical evidence active infection Antibiotic treatment within 7 day prior enrolment Gastrointestinal haemorrhage within previous 2 week Use immunomodulating agent within previous month ( steroids etc . ) Use proton pump inhibitor precede two week Concomitant use supplement ( pre , pro , synbiotics ) likely influence study Renal failure ( hepatorenal syndrome ) , creatinine &gt; 1.7 mg/dL Hepatic encephalopathy II IV Pancreatitis Other organ failure Hepatic extrahepatic malignancy Pregnancy Presumed noncompliance study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>